Extracellular vesicles (EVs) are microscopic messengers ejected by cells, pivotal for intercellular communication and involved in varied biological roles from immune responses to cancer development. Given their potential in diagnostics and therapy, isolating EVs efficiently is essential but has long suffered from cumbersome, equipment-heavy methods like ultracentrifugation.
A groundbreaking solution has emerged from Korea University College of Medicine, where researchers, led by Professor Nakwon Choi, have crafted an innovative hydrogel-based platform spotlighted in Nature Nanotechnology. This high-throughput method relies on meso–macroporous hydrogels formed through cryo-photocrosslinking, facilitating efficient EV isolation without reliance on complex machinery or extensive prep work.
The hydrogel framework captures EVs via charge-selective interactions in a high-salt setting, allowing for simple release once the salt is removed. This enables effective EV isolation from various biofluids like blood, urine, and milk. Remarkably, the new platform yields EVs at significantly higher rates—up to 1,539 times more from milk—while cutting down processing time almost sixfold compared to traditional methods.
This advancement not only enhances scalability across different biofluid volumes but also preserves the EVs’ structural integrity, crucial for future biochemical applications. Additionally, the freeze-dried hydrogels provide long-term stability for EVs without refrigeration, adding practicality for under-resourced settings.
The implications of this technology extend to numerous diagnostic applications, offering non-invasive detection of disease biomarkers in easy-to-collect fluids like urine and saliva. Its therapeutic potential in areas like wound healing and tissue regeneration is underscored by its ability to maintain EV functionality.
This hydrogel-powered approach marks a significant leap in EV technology, proposing a user-friendly, cost-effective, and scalable method of EV isolation and preservation. It paves the way for expanded EV-based diagnostics and therapies, broadening their accessibility in research and industrial contexts without heavy resource investment. The efforts of Professor Choi and his team unlock vast possibilities for transforming lab discoveries into real-world medical and industrial innovations.